Bayesian Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-28,415
| Closed | -$398K | – | 1005 |
|
|
2024
Q3 | $398K | Buy |
+28,415
| New | +$398K | 0.05% | 423 |
|
|
2024
Q2 | – | Sell |
-22,935
| Closed | -$177K | – | 1107 |
|
|
2024
Q1 | $177K | Buy |
+22,935
| New | +$177K | 0.02% | 669 |
|
|
2023
Q3 | – | Sell |
-29,733
| Closed | -$457K | – | 1009 |
|
|
2023
Q2 | $457K | Buy |
+29,733
| New | +$457K | 0.05% | 426 |
|